Companies like INOVIO, Ocugen, and Pfizer are advancing research on next-generation Covid-19 vaccines due to the evolving virus. INOVIO's Phase I trial showed promising results with DMAbs, while Ocugen and Pfizer are progressing with clinical trials for their respective vaccine candidates.